Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

AIMS: Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequently used...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:ESC Heart Fail
Main Authors: Schueler, Stephan, Silvestry, Scott C., Cotts, William G., Slaughter, Mark S., Levy, Wayne C., Cheng, Richard K., Beckman, Jennifer A., Villinger, Jonas, Ismyrloglou, Eleni, Tsintzos, Stelios I., Mahr, Claudius
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Original Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318455/
https://ncbi.nlm.nih.gov/pubmed/34047072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13401
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares